Lithography based methods to manufacture biomaterials at small scales 2017 Journal of Science Advanced Materials and Devices

Lithography based methods to manufacture biomaterials at small scales 2017 Journal of Science Advanced Materials and Dev...

Journal of Science: Advanced Materials and Devices (2017) 1e14 Contents lists available at ScienceDirect Journal of Science: Advanced Materials and Devices journal homepage: www.elsevier.com/locate/jsamd Review Article Lithography-based methods to manufacture biomaterials at small scales Khanh T.M Tran a, Thanh D Nguyen a, b, * a b Department of Mechanical Engineering, University of Connecticut, United States Department of Biomedical Engineering, University of Connecticut, United States a r t i c l e i n f o a b s t r a c t Article history: Received 20 November 2016 Received in revised form 30 November 2016 Accepted 11 December 2016 Available online 21 December 2016 Along with the search for new therapeutic agents, advanced formulation and fabrication of drug carriers are required for better targeting, sensing, and responding to environmental stimuli as well as maximizing treatment efficiency The emergence of intelligent therapeutics involves the use of functional biomaterials to mimic biological system for prolonged circulation and to work harmoniously with the body One of the main concerns lies in the feasibility of creating systems with well-defined architectures including size, shape, components, and functionality This review provides an overview regarding current challenges and potential of manufacturing and fabrication of biomaterials at small scales for various biomedical applications Accordingly, novel lithography-based fabrication approaches are introduced together with their remarkable applications Besides being popular in microelectronics, lithography techniques have demonstrated a great potential use for drug delivery, tissue engineering, and diagnostic tools © 2017 The Authors Publishing services by Elsevier B.V on behalf of Vietnam National University, Hanoi This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) Keywords: Lithography Biomaterials Intelligent therapeutics Drug delivery Tissue engineering Biosensors Introduction The use of biomaterials is ubiquitous in biomedical applications which include drug delivery systems, engineered tissues, and biomedical devices Biomaterials are defined as synthetic or natural materials which are in contact with biological environment in order to treat any malfunctions of the body [1] Accordingly, biomaterials must function synergistically with the body and possess sufficient biocompatibility to avoid the risk of being recognized and eliminated by the immune system Biocompatibility which is described as “the ability of a material to perform with an appropriate host response in a specific application” by Williams [2] is prerequisite for any materials operating in human body Biomaterials are tailored in such a way that they are able to resist the immune response, blood clotting, or bacterial colonization Biomaterials have been widely investigated and implanted in human body for applications such as skeletal repair, organ replacement, and improvement of senses, among many others with remarkable success Artificial hip joint is one of the most popular implants * Corresponding author Department of Mechanical Engineering, University of Connecticut, United States E-mail address: nguyentd@uconn.edu (T.D Nguyen) Peer review under responsibility of Vietnam National University, Hanoi employing biomaterials [3] Hip joint prostheses are composed of titanium, stainless steel, special high strength alloys, ceramics, composites and ultra-high molecular weight polyethylene The replacement of worn-out hip joint helps restore patient ease of movement Likewise, heart valve prostheses also contribute to treat cardiac abnormalities [4] These implants are made of carbons, metals, elastomers, plastics, fabrics together with chemically pretreated animal or human tissues to diminish immunologic activities Other examples in this area include dental implants, cochlear replacement, contact lenses, etc [5] These types of implants are expected to possess adequate protection from degradability in order to exhibit long term stability in the biological system On the other hand, biodegradability is essential for micro- and nanosystems to avoid invasive removal surgeries and possible toxicity innate to long-term implantation Furthermore, biodegradability can facilitate control over drug release profile To this extent, the notion of intelligent therapeutics has evolved with the growth of biomaterials in response to the demand to manufacture improved functional systems Apart from their role as therapeutic carriers, these systems are created to be capable of advanced targeting or stimulating delivery, as well as detection/ diagnoses of diseases In the interest of fabricating intelligent therapeutics, these systems need to be responsive to a biological environment To so, it is necessary for them to imitate the nature http://dx.doi.org/10.1016/j.jsamd.2016.12.001 2468-2179/© 2017 The Authors Publishing services by Elsevier B.V on behalf of Vietnam National University, Hanoi This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 2 K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 of their surrounding in terms of characteristics, sizes, and structures, which together present compelling challenges for scientists to overcome So far, significant chemical progresses have contributed to the success of producing micro- or nano-sized bio-systems that are suitable for certain kinds of diseases Current attempts have mainly involved the employment of polymers and lipids to form drug particles through chemical cross-linking, emulsion, selfassembly, and dispersion alongside with chemical moiety modification for enhancing penetration, prolonging circulation, and controlled delivery [6,7] However, particular difficulties remain in synthesizing precise architectures with regard to size, shape, and components as well as manipulating functionalized properties [8,9] Recent works have explored physical micro- and nanofabrication methods in addition to conventional chemical ones, offering superior techniques for drug delivery, tissue engineering, biosensing, and disease-diagnostics Lithography is a micro- and nano-fabrication technique that enables formation of precise and complicated two-dimensional or three-dimensional structures at extremely small scales The technique originated from a method of planographic printing on smooth surfaces of a plate or stone This method was invented by the work of a Bavarian author, Alois Senefelder, in 1976 [10] The application of lithography has advanced the field of electronics by enabling the mass production of semiconductors, electronic components and integrated circuits [11] In the early twentieth century, there was a limited use of photolithography for biomedicine despite the development of advanced techniques in micro-patterning This was mainly due to the high cost, complex operation and inaccessibility of photolithography techniques to scientists [12] Later on however, momentous growth of lithography has occurred due to increased access to fabrication tools (clean-room facilities) in many research institutes as well as lowering costs of production This further became a driving force to expand lithography for studies in science and technology, especially in biomedical areas [13] Early works include the development of Bio-microelectromechanical systems (Bio-MEMS), nanoelectromechanical systems (NEMS), microfluidics, photonics, optics, and multifunctional devices Moreover, the advantages of creating well-controlled morphology present alternative opportunities to create intelligent therapeutics; subsequently, there is a significant interest in further exploration of these approaches This review aims to provide the current status of chemicallyfunctionalized biomaterials at micro- and nano-scales and further describe advances in employing lithography-based micro- and nano-fabrication methods, producing biomaterials for medical applications Functionalized biomaterials for biomedical applications 2.1 Functionalized biomaterials with certain physical and chemical properties to cross biological barriers In the attempt to administer therapeutic agents, the foremost concern is their ability to bypass natural barriers The presence of these barriers primarily serves as ultimate regulating entrances of solutes and compounds; thereby, protecting the body against invasion of foreign factors One of the most restrictive barriers in human body to be mentioned is blood brain barrier which only permits diffusional transport of small lipid soluble molecules with molecular weight under 400 Da [14,15] The gastrointestinal barrier, although viewed as a highly vascularized surface, presents selective uptake activity by composing of enterocyte membranes, tight junctions and specialized immunologic factors [16,17] Another type of barrier is the stratum corneum (SC) situated on the upper layer of skin SC is comprised mainly of multiple lamellar bilayer corneocytes surrounded by an extracellular milieu of lipids; hence, it only prefers entrance of low molecular weight lipophilic compounds [18] These barriers together pose considerable challenges to the field of drug delivery To deliver drug into desired organs, it is therefore desirable to deceive the barriers by creating drug carriers with special functions This requires the modulation of physical and chemical features of drug particles One of the initial efforts is to reduce particle size of drugs to the range of nano to a few microns There are two common approaches to fabricate nanoparticles in which the particles are built up from molecules (bottom up) or partitioned from larger ones (top down) Although small particles are proven to cross the barriers more effectively, nanoparticles with diameters smaller than nm can be excreted by kidneys [19], whereas those larger than 200 nm might accumulate in the spleen and liver Nevertheless, the particle size is not the only concern in designing a drug delivery system In a review by Albanese and coworkers [20], they studied the correlation between the properties of nanomaterials (size, shape, chemical functionality, compositions, and surface charge) and theirs biomolecular signal, kinetics, distribution, and toxicity For instance, Yan Geng et al [21] showed that rod-shape micelles could prolong circulation when compared to spherical ones Also, the surface charge of particles have effects on blood half-life Neutral nanoparticles possess the highest circulation time whereas other charges result in fast clearance, or interact with proteins (e.g immunoglobulin, lipoproteins) occurring in body fluids causing hemolysis, platelet aggregation, and coagulations [22] Besides efforts to modify physical properties of therapeutic particles, functionalized particles can promote transport across different biological barriers [23] These include the employment of uptake-facilitating ligands such as apolipoprotein E (ApoE) [24] and transferrin [25] for drug delivery to brain or co-administration with P-glycoprotein inhibitors [26] for oral delivery or penetration enhancers [27,28] for transdermal delivery 2.2 The use of biomaterials for controlled drug delivery Since each of therapeutic agents possesses unique properties in terms of water-solubility, crystallinity and chemical characteristics, they need to be encapsulated into appropriate carriers or biomaterials prior to manufacturing in order to meet individual compatibility and maximal drug-efficiencies Several techniques to formulate drug delivery systems are comprehensively developed, namely liposomes [29], micelles [30], emulsions [31,32], solid lipid nanoparticles [33], solid dispersion [34,35], drug-cyclodextrin complexation [36,37], and prodrugs [38,39] Due to the poor water-solubility of some therapeutic agents and the nature of biological barriers, the formulated systems usually possess certain degree of hydrophobicity Additionally, these formulations require extensive use of additives for stabilization and prevention of coalescence These additives are, however, associated with potential toxicity This concern demands the implementation of biomaterials with Food Drug Administration (FDA)’s approval and biodegradability The search for sources of natural and synthetic polymers suitable for biomedical applications has been widely carried out [40] Designs of drug delivery systems have to be in accordance with different routes of administration and purposes of treatment A challenge for most biomaterials entering the body is the risk of being eliminated In a common approach, rapid clearance by phagocytic cells of mononuclear phagocyte system can be avoided by attaching polyethylene glycol (PEG) to surface of the particles This process, alternatively so-called PEGylation, prevents opsonization, thereby enhancing blood half-life of biomaterials [41] PEG is approved by the FDA for usage in foods, cosmetics, and pharmaceuticals with little toxicity and is able to be further eliminated K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 in urine or feces [42,43] Pegylated liposomes that form hydrated cover have shown positive impacts not only on extending circulation time, increasing half-life, and decreasing plasma clearance by protection from proteins and reticuloendothelial uptake but also better drug encapsulation and leakage prevention, thereby maximizing treatment efficacies [44,45] 2.3 The use of biomaterials for tissue engineering Biomaterials contribute to engineered tissues to replace parts of the human body and harmoniously function with biological systems [1] There exist several interests to engineer tissue properties and performance by using biomaterials The interference of tissueengineered products with the extracellular fluids is significant since it would trigger an inflammatory response Considering potential long-term toxicity, biomaterials which have a degradability rate matching with tissue regeneration rate are desirable In accordance with dysfunctions of native organs, the implanted tissues would preferably start to operate at time of treatment to replace impaired ones Alternatively, they may convert into expected form upon implantation [46] Thus, the composition, architecture, 3D environment of the scaffold, and biocompatibility of materials are challenging factors that strongly impact formulation of implanted tissues [47] Biomaterials should be processable to complex shapes with porosity and sufficient mechanical strength [48] Moreover, consistency and uniformity are requirements to manufacture tissueengineered products Also, tissue and cell preservation from function loss during long-term storage needs to be improved [49] Efforts have also been made to mimic the extracellular matrix for tricking the body immune response A number of natural materials have been employed to this end including alginate [50], chitosan [51], hyaluronic acid [52], etc Another attempt is to incorporate signal peptides (RGD) into materials [53] Chemical modulation of biomaterials Numerous efforts have been made to study and obtain desired properties of biomaterials for different medical applications Chemical methods have been tremendously used to successfully modulate biomaterials by adding or combining functional chemical groups, which can response to specific stimuli and environments As such, we briefly cover some important chemical modulations before describing in more details lithography-based technology as a powerful supplemental approach to manufacture biomaterials 3.1 Responsive-biomaterials Considerable amounts of agents used for pharmacotherapy may exhibit side-effects besides advantageous activity when delivered to wrong targets or healthy tissues This phenomenon is usually present in cancer therapy in which cytotoxic compounds can kill normal cells in addition to cancer cells Efforts have been made toward chemical modifications of biomaterial carriers' structures and surfaces for specific delivery or drug targeting [54] The implications of stimuli-responsive biomaterials propose an opportunity to fabricate active drug carriers that can release therapeutic agents through particular triggers including biological stimuli such as pH, temperature, redox microenvironment or artificial stimuli such as light, magnetic, etc In a review by Ganta et al [54], various stimuliresponsive nano-systems are comprehensively discussed According to Caldorera-Moore et al [55], responsive biomaterials can be categorized into two groups The first group refers to passive carriers which respond to external conditions (pH, thermodynamic, ionic strength, magnetic, and electrical) by physicochemical interactions On the other hand, functionalization of materials can be performed to form ligand receptors which interact and act in response to biomarkers or bioanalytes present in a medium or diseased tissue 3.2 Polymer-based biomaterials Many polymer-based biomaterials have been widely studied Among them, crosslinking hydrophilic polymers or hydrogels appear as one of the most potentially effective systems for medical applications since they permit the incorporation of functional groups directly into theirs networks Additionally, the high water affinity and swelling property of hydrogels are believed to importantly contribute to their interesting behaviors towards environmental stimuli The working mechanism of such responsiveness relies on the side chain groups, branches, and crosslinking structures of polymeric materials The pH-sensitive hydrogels consisting of pendant acidic and basic groups (e.g carboxylic, sulfonic acids, ammonium salts) can simultaneously accept or release protons corresponding to medium pH through movement of solutions into the networks [56] as presented in Fig Some of the most studied polymers for this area to be named are poly(acrylic acid) (PAA) [57], poly(N,N9-diethylaminoethyl meth acrylate) (PDEAEM) [58], poly(methacrylic acid) (PMA) [59], carrageenan, alginate [60] etc The pH-sensitive hydrogels have been applied to control drug release rate in a gentle manner for specific sites such as gastro-intestinal [61e63], transdermal [64e66] A recent review by Karimi and coworkers [67] has thoroughly addressed several stimulus-responsive nano-carriers for controlled drug release Besides pH sensitivity, other environmentally sensitive systems have been investigated [68] Several polymers possess reversible phase transitions upon temperature variations owning to the presence of hydrophobic groups namely methyl, ethyl, and propyl [69] Different polymers have been widely studied for these works are poly (N-isopropylacrylamide) [70], poly (N-vinylcaprolactam) [71] Efforts have been made to create multi-functional systems for better drug transporting and targeting [72e74] Furthermore, hydrogels have presented great applications for tissue engineering scaffolds which are discussed in several papers [7,75,76] due to their high density and structural support while preserving in vivo environment Another polymer-based system is emulsified microparticles, so-called microemulsions Microemulsions are isotropic, thermodynamically stable systems of oil, water, and surfactant, frequently in combination with a co-surfactant [77] The performance of microemulsion as drug delivery systems is remarkable Their low surface tension and small droplet size enhance the absorption and permeation rate through membranes Solid dispersion has also been studied as an effective strategy for drug delivery systems The process creates active ingredients dispersed in an inert carrier matrix [78] The enhanced dissolution rate of drug by solid dispersion may contribute to the increased drug solubility due to the reduction of the dispersed particle size, conversion from crystalline to amorphous state, and drug wetting improvement The two most common methods used to produce solid dispersion are melting and solvent evaporation Several polymers that have been tested as carriers for solid dispersion systems, including PEG, polyvinyl pyrrolidone (PVP), cellulose derivatives, polyacrylates, and polymethacrylates, among many others [79] Table lists different lithography-based methods which could be used to manufacture such polymer-based biomaterials 3.3 Limitations of current chemical methods and the need of lithography-based technology Despite tremendous advantages and achievements of chemical methods, the clinical utilizations of chemically-engineered nanoand micro-carriers have been limited by the difficulties associating with uniformity and consistency in terms of controlling specific K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 Fig Diffusion of drug in response to pH variations [166] Table Lithography-based technology in forming polymer-based biomaterials Lithography-based technology Polymer-based biomaterials Method Advantages References Photolithography Proteins, cells, extracellular matrices Photon upconversion lithography (PUCL) [152] Soft lithography Emulsified polymeric systems Microfluidic devices Photolithography Solid dispersion polymeric systems PVP solution was dispensed into lithographically patterned microcontainers Ketoprofen was impregnated in polymer matrix by using supercritical carbon dioxide e loading medium Providing high resolution in noncontact manner which prevents contamination Less photo-damage by the use of near infrared light and deeper penetration into tissues Large scale pattering Systems with better control over size, structure, and composition Scalability, low cost, reproducibility, and high throughput Higher efficiency when compared to conventional dispersing methods size, shape, chemical components, and functionality [80,81] For instance, self-assembling structures such as liposomes, micelles, emulsions exhibit a dynamic instability, thereby presenting challenges in manipulation of exact size, shape, and drug encapsulation or dosing [82,83] The emergence of lithography-based techniques to engineer micro- and nanocarriers and to produce better controlled system properties has offered a promising alternative in the field of biomedicine One of recent papers in our group has thoroughly addressed up-to-date applications of advanced 3D technologies to create well-structured micro- and nano-carriers for controlled drug delivery system [84] Lithography technology 4.1 Photolithography Photolithography or optical lithography is defined as a process using light to transfer patterns from a photomask to a photoresist (light-sensitive chemical) on a substrate and then selectively remove unused parts out of the substrate Photolithography technique is based on a top down approach Different processing protocols and materials are required for different implementations of photolithography; however, they largely follow a basic common procedure as presented in Fig To prepare for photoresist coating, a substrate like silicon wafer must be removed of any contaminants [146] [171] Higher precision of drug dosing is obtained together with better dissolution results including solvents stains (methyl, alcohol, acetone, etc.), dust from atmosphere, operators, and equipment, microorganism, aerosol particles, etc on the surface [85,86] The process requires operation under cleanroom facilities enclosed in a strictly environmentally controlled space in terms of airborne particulates, temperature, air pressure, humidity, vibration, and lighting [87] For certain cases especially in biomedical applications, the silicon wafer basically serves as a solid support on which additional layers of materials are deposited due to its ideal characteristics namely rigid, flat, low cost, and smooth [13] The wafer is coated with a thin layer of photoreactive materials that generally are monomers, oligomers, or polymers For patterning biomaterials like proteins and cells, nearinfrared (NIR) light is more preferable than UV since it is less photodamaging and deeper penetration [88] To this extent, depending on the nature of photoresists, there are different ranges of radiation which can be used such as electron beams, ion-beam, and X-ray The fundamental principle of photolithography lies in the chemical alterations of the resist upon light exposure [89] By shining UV light through a photomask which consists of non-transparent patterns printed on a transparent plate, the patterns are transferred onto the photoresist In the next developing step, the remaining parts of the photoresist after exposure relied upon whether positive or negative photoresist is employed which subsequently dissolve exposed and unexposed regions respectively Photolithography has established a fundamental foundation for further development of other advanced methods (see Fig 3) K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 Fig Schematic of photolithography [167] (a) The wafer is cleaned to remove any unwanted contaminants (b) The photoresist is spin coated onto the wafer (c) The photomask is placed above the photoresist UV light is exposed through the mask (d) The unexposed part is removed by solvents leaving the desired patterns Fig Schematic process of (a) polymer mold fabrication from a master and (b) UV nanoimprint with the polymer mold Reprinted from reference [168] with permission from Elsevier 4.2 Advanced lithography-based methods 4.2.1 Soft lithography Despite the fact that photolithography is prevalent in both microelectronics and biomedical fields, there exists certain limitations restricting it from being suitable for all applications For example, the process of photolithography requires expensive facilities (cleanroom, photomasks fabrication, projecting systems) The conventional lithography techniques, although being wellestablished in semiconductors industry, encounter noticeable impediments owning to the rigorous processes Several manufacturing steps such as cleaning, baking, exposing, which require the presence of high-temperature, ion-etching, solvents, often result in degradation of biomaterials [90] Additionally, photolithography has neither control over surface chemistry nor implementations on curved/non-planar surface [91] Based on the conventional method of lithography, scientists have developed an alternative set of micro-fabrication working on “soft-matter” (organic materials, polymers, complex biochemical) and the pattern-transfer by molding using elastomeric biomaterials named as soft lithography [92,93] The method of soft lithography is fundamentally based on printing, molding, and embossing and has been extensively described in many literatures [12,91,94] Soft lithography involves techniques of using elastomeric stamps, molds, and photomasks to fabricate or replicate structures [94] Some of the most well-studied patterning techniques are microcontact printing (mCP) [95], replica molding (REM) [96], micro- and nano-transfer molding [97,98], solvent-assisted micromolding (SAMIM) [99], phase-shifting edge lithography [100], decal transfer lithography [101], and nanoskiving [102] 4.2.2 Nanoimprint lithography Nanoimprint lithography is defined as the process of pressureinduced transferring of patterns from a rigid mold to a thermoplastic polymer film heated above its glass transition temperature This method alternatively refers as hot embossing Recent review K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 by Traub et al [103] has extensively discussed the principle of nanoimprint lithography and its wide applications in different fields Essentially, the nanostructured mold is duplicated in a thin resist film casted on a substrate by applying adequate pressure [104] This stage involves heating the resist above its glass transition temperature where it becomes viscous and deformable into shape The mold is then removed together with residual resist in the compressed parts Since the process is associated with heat and pressure, it is important to select appropriate resist materials which have relatively small thermal expansion and pressure shrinkage coefficients Bender et al [105] first introduced a modified nanoimprint lithography operating at room temperature and low pressure, which is based on UV-irradiation and photopolymerization (Fig 1) Similarly, the polymer UV-transparent mold (quartz or silica) is pressed onto the substrate coated with UV-curable resist Following exposure, the precursor liquid crosslinks and constructs stable patterns Ever since introduction, nanoimprint has made a significant progress due to its simplicity, efficiency, high throughput, and low production cost Moreover, research pertaining to the field includes enhancing resolutions of the patterned nanostructures [106] To this extent, Koo et al [107] investigated the effects of mold materials on the fabrication process Their works showed that toluene diluted poly(dimethylsiloxane) (PDMS) was capable of homogeneously defining 50 nm resolution patterns on in wafer with single imprint Other concerns and applications regarding nanoimprint techniques to fabricate biomaterials have been addressed in several literatures [108,109] 4.2.3 Nano-molding PRINT particles The method of Particle Replication In Nonwetting Templates (PRINT) was first developed by DeSimone et al in 2004 Ever since, it has drawn significant attention from scientists due to its ability to generate monodisperse micro- and nano-carriers with simultaneous control over particle size, shape, composition, and functionalities by employing the advances of soft lithographic molding technology The initial effort in the PRINT process is to formulate particle composition liquid which consists of essential chemotherapeutics or functionalized features Different particles ranging from 80 nm to 20 mm, composed of poly(D-lactic acid) (PDLA) and derivatives [81], PEG hydrogels [110,111], and proteins [112] have been successfully manufactured Secondly, the solution is then placed onto a prepared mold and allowed for solvent evaporation or polymerization The stage involves the process to pattern replica molds with desired size and shape to emboss liquid precursor compounds In this regard, the silicon master templates were firstly constructed by patterning silicon wafer coated with poly(methyl methacrylate) (PMMA) resist using e-beam lithography Subsequently, photocurable perfluoropolyether (PFPE) was pooled onto the templates and chemically cured to form elastomeric PFPE molds [113] PFPE appears to be one of the most suitable materials because of its nonwetting and nonswelling fluorinated surfaces to both organic and nonorganic solvents [114] This enables the creation of isolated, harvestable “scum-free” particles without harsh processes With this in mind, the final step following mold filling is to harvest the particles One physical method uses the sharp end of a glass side to remove the particles; however, numbers of disadvantages arise that are damaging the mold surface, aerosolizing dry particles, and inability to scale the process Hence, a gentler process was investigated by laminating an adhesive release layer such as PVP or cyanoacrylate on a flexible or rigid backing PET or glass slides on the open side of the mold After that, the mold is peeled away, leaving the array of free-standing particles Dissolution of the adhesive film results in free-flowing particles in solutions [115] Additional purification steps are performed accordingly such as dialysis, centrifugation, filtration, and magnetic purification in order to eliminate residual or debris chemicals [113,116] Applications of advanced lithography-based methods for biomedicine 5.1 Drug delivery systems 5.1.1 PRINT particles PRINT has offered an advanced lithography-based method to operate with a wide range of organic materials containing biological elements such as oligonucleotides, proteins, pharmaceuticals, and synthetic viruses In a studied by Gratton et al [113], cellular internalization, cytotoxicity of monodisperse mm cylindrical PRINT particles and the effect of surface charge on endocytosis were investigated using confocal microscopy, flow cytometry, and transmission election microscopy Fig describes the result of PRINT fabrication process The particles were readily distributed into tested cells: HeLa, NIH 3T3, OVCAR-3, MCF-7, and RAW 264.7 with little cytotoxicity obtained Also, higher endocytosis rate was observed in particles with positive zeta potential as compared to negative ones On-going research in the field focuses on formulating stimuli response targeted nanoparticles [117,118] All in all, PRINT e a highly versatile method - has become uniquely suitable for large scale manufacturing monodisperse organic and nonorganic nanoparticles with precise size, shape, composition, surface properties dedicating to applications in nanomedicine 5.1.2 Nanoimprint applications Nanoimprint is suitable for various polymeric materials such as biomolecules [119,120], block copolymers [121,122] with feature sizes down to nm and high aspect ratios In a remarkable study of Glangchai et al [8], by employing nanoimprint techniques, they were able to synthesize enzyme-triggered release nanoparticles of antibodies (Streptavidin-CY5) and nucleic acids (plasmid DNA) with well-defined sizes and geometries (square, triangular, pentagonal) The responsive and biocompatible properties were obtained through combination of PEG diacrylates (PEGDA) or dimethacrylates (PEGDMA) polymers and an acrylated, enzymatically degradable peptide Gly-Phe-Gly-Lys-diacrylated (GFLGK-DA) Additional biocompatible photoinitiator (2-hydroxyl-1-[4-(hydroxyl)phenyl]-2-methyl-1-propanone) was added to trigger photopolymerization when performing UV exposure Nanoimprinting was conducted using the Step and Flash Imprint lithography (S-FIL) method (Fig 5) After imprinting, the nanoparticles were isolated by reactive ion etching (RIE), removing residual areas between particles And the nanoparticles were collected into poly(vinyl alcohol) (PVA) solutions Elucidations and drug release studies demonstrated the efficiency of nanoimprint to fabricate longcirculating nanocarriers as small as 10 nm with controlled size and shape which responded to environmental stimuli Also, the method proved its mildness for biological agents without the use of high temperature, high shear, extended UV exposure, and organic solvents The presence of available groups to attach specific ligands on the chemical structures of formulated materials offers great opportunities for targeted drug delivery and imaging [123] 5.1.3 Microneedles Transdermal delivery emerges as a potential route of administration since it offers a direct drug application to an affected site, steadier drug concentration in plasma, and limits systemic exposure by the absence of hepatic first pass metabolism [124] Yet, the presence of stratum corneum (SC) as skin barrier functions as the most significant regulator for entry into the body SC prevents entrance of therapeutic agents except for that of lipophilic and low K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 Fig Results of the PRINT process Top row, left to right: a) SEM of an etched silicon wafer master template of mm posts having a height of 1.7 mm; b) cured PFPE mold of the master template shown in A; c) PFPE mold containing PEG particles prior to harvesting; d) harvested and dispersed PEG PRINT particles Bottom row, left to right: e) SEM of an etched silicon wafer patterned with approximately 400 billion posts that are 100 nm in diameter and 400 nm tall; f) a cured PFPE mold of the silicon master template shown in E; g) 100 nm PEG particles made using PRINT and transferred to a medical adhesive layer for surface functionalization and subsequent harvesting Reprinted from reference [169] with permission from Elsevier Fig Step and Flash Imprint lithography (S-FIL) method: PVA release layer and PEGDA is applied to BARC coated silicon surface The quartz template is pressed onto PEGDA and exposed to UV light The template is removed to reveal particles with thin residual layer Brief oxygen plasma etch is performed to remove residual layer Particles are harvested directly in water or buffer by one-step dissolution of the PVA layer Reprinted from reference [8] with permission from Elsevier weight molecules Efforts have been made to formulate in situ topical applications, particularly patches [125], gels, and creams [126] Some of the well-studied systems in this field are available in the market [127] However, these conventional systems possess certain disadvantages namely high viscosity, lack of flexibility, visibility, and inadequate retention on skin which then requires repetitive dosing and poor patient compliance For the past decade, microneedles have provided a straightforward method to directly administrate therapeutic agents bypassing the SC in a minimallyinvasive manner [128] The system only needs to pierce pass 10e15 mm nerve-free layer for drug to diffuse through the highly permeable viable epidermis to capillaries Unlike regular hypodermic needles, microneedles create micro-dimensional painless pathways to transport small drug particles, macromolecules, proteins, and fluid with a high localization, correct-targeting, and controlled release The development of microneedles has been accompanied by the revolution of lithography methods in biomedical research The first attempt to produce microneedles based on photolithography techniques was reported by Henry et al in 1998 [129] In this process, 〈100〉-oriented, prime grade, 450e550 mm thick, 10e15 U-cm silicon wafers supplied by Nova Electronic Materials Inc (Richardson, TX) were initially cleaned in a mixture of deionized water, hydrogen peroxide, and ammonium hydroxide at approximately 80  C for 15 min, and followed by dehydration baking at 150  C for 10 Chromium was deposited onto the wafers and patterned into 20 Â 20 arrays of 80 mm diameter dots with 150 mm center-to-center spacing by UV exposure of the K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 photoresists coated on a chromium layer Through immersing the wafers to a liquid developer, the exposed photoresists were removed Then the chromium exposed during previous photolithography was etched, revealing dot arrays of chromium on the silicon wafers which were further used as masks for microneedle fabrication Solid microneedles were manufactured by deep reactive ion etching (RIE) silicon substrates with 20 standard cm3/min (sccm) SF6 and 15 sccm O2 at a pressure of 20 Pa and power of 150 W for roughly 250 [130] The parts covered with chromium formed the microneedles The etching was continued until the masks completely under-etched and fell off, forming arrays of sharp silicon spikes From this early study, microneedles demonstrated their potential in painlessly piercing into skin without breaking or disrupting skin nature Additionally, in vitro results indicated enhanced calcein permeability by 25000-fold and prolonged release for h Microneedles have opened a new perspective for transdermal delivery Despite the fact that silicon possesses comprehensive processing experience, it is considered to be fragile, arguably biocompatible, and comparably expensive [131] Later works have employed metals [132], glass [133], ceramics [134], and biodegradable polymers [135] to fabricate microneedles in different shapes and sizes for specific applications Solid microneedles were later manufactured to possess beveled-tip, chisel-tip, and taperedcone needles as presented in the work of Park et al [131] The fabrications are fundamentally based on conventional photolithographic process, etching, laser cutting, metal electroplating, electropolishing, and micromolding [136e139] A review by McAllister and co-workers [140] has extensively described different approaches using metals and polymers for transporting macromolecules and nanoparticles Generally, microneedles are classified into solid microneedles including drug-coated microneedles, dissolving microneedles and hollow microneedles (Fig 6) Properties of each kind are discussed in Table For instance, Fig (a) Solid microneedles, (b) Coated microneedles, (c) Dissolving microneedles, (d) Hollow microneedles Reprinted from reference [170] with permission from Elsevier Table Comparison of different microneedles fabricating approaches [170] Types of microneedles Drug loaded Dipping or spraying drugSolid Coated microneedles microneedles formulated solution onto solid microneedles Additional use of [172] surfactants to facilitate wetting process and stabilizing agents, which protect drug from drying and storage Dissolving Therapeutics are encapsulated in microneedles formulated polymers which are able to solidify or polymerize during micromolding Hollow microneedles Therapeutics especially in liquid formulations are entrapped in the reservoir and injected through the hollow space of microneedles Release mechanism Limitations Applications Drug coated on microneedles dissolves into tissues upon insertion and contact with biofluids Limit to drugs with small doses Coating solutions should possess water-solubility, good mechanical resistance, and pharmaceutical acceptance The polymer microneedles completely dissolve or degrade in the skin as responding to stimuli (temperature, pH, solvents), and leaving no biowastes after administrations The flow of liquid through microneedles is generated using a syringe of actuators that are controlled by CO2 gas pressure, a spring, a piezoelectric micropump, a piezoelectric linear servo motor, a syringe pump and a micro-gear pump [193,194] Some formulations require long remained time on skin to sufficiently dissolve Materials and fabrication methods should be carefully tailored for specific therapeutic agents Fluid flow rate in certain cases might depends on insertion depth, pressure, needle tip shape, and spreading factor [195] Hollow microneedles require more advanced fabrication techniques than previously mentioned ones Small molecules: vitamin B, fluorescein [173] Macromolecules: insulin [174], verapamil hydrochloride and amlodipine besylate [175], epigallocatechin-3-gallate [176], hormone [177], bovine serum albumin [178], desmopressin [179] Vaccines [180]: hepatitis B surface antigen [181], influenza virus [182], human papillomavirus [183], measles vaccination [184], inactivated chikungunya virus [185], hepatitis C DNA vaccine [186], herpes simplex virus [187] Sulforhodamine [188], insulin [189], erythropoietin [190], human growth hormone [191], Hepatis B vaccination [192] Insulin [196], doxorubicin [197], phenylephrine [198], vaccine [199], inactivated polio vaccine [200] K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 hollow microneedles have been developed as means of delivering insulin and vaccines by infusion [132] In fact, hollow microneedles have adapted techniques in MEMS fabrication Similarly, photoresist was deposited and patterned onto silicon wafers Straight-walled holes were yielded by utilizing Bosch modified inductive coupled plasma reactive ion etching (ICP-RIE) [141] Another interesting work by Kim et al [142] designed a responsive system to separate microneedles into skin upon contacting the biofluid, which was triggered by swelling of hydrogels The polyNisopropylacrylamide (PNIPAAm) hydrogels microparticles prepared by emulsification method were filling into the cavities of the mold prior to microneedle construction by micromolding polylactic-coglycolic acid (PLGA) The systems were studied in vivo by inserting microneedles to porcine cadaver skin Sustained drug release evaluation was performed in vitro through Franz cell model The drug release mechanism was due to the dissimilar degrees of swelling among hydrogels and needle matrix polymer causing cracking of microneedles In vivo study on mouse skin has also drawn analogous findings that the formulated microneedles successfully released drug into the skin Collectively, fabrication of microneedles for transdermal drug delivery using lithographybased method has been on the edge of development due to the ability of microneedles to effectively drive drugs into skin in a controlled and targeted manner together with high patient compliance and ease of large scale production 5.1.4 Microfluidic devices to fabricate drug particles Microfluidic devices offer powerful tools to fabricate monodisperse microparticles in a high throughput manner [143] The most common materials used to manufacture microfluidic devices are (PDMS) Employed in the photolithography fabricating process, PDMS enables formation of small scale and complex channels in the devices (Fig 7) Briefly, the SU-8 photoresist is coated in silicon wafer and patterned The resist structures are further used as negative mold masters to pattern PDMS The PDMS is poured over the mold master and cured for h at 70  C After being peeled off, the PDMS mold is attached to a glass slide for further serving as microfluidic devices [144] In a study by Xu et al [145], monodisperse biodegradable drug-loaded microparticles were successfully fabricated by microfluidic flow-focusing generators and rapid solvent evaporation from resulting droplets The particle size could be modulated through controlling the flow conditions within the devices Drug release studies had shown that particles prepared by this method exhibited critical reduction in burst release effect and slower release rate in comparison with conventional emulsion methods; hence, presenting potential for prolonging drug release Fig Basic microfluidic device fabricating process Reprinted with permission from reference [144] Copyright 2002 American Chemical Society Fig Schematics of bilayer embossing process The inset shows the top-view of the skeleton Reprinted from reference [156] with permission from Elsevier 10 K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 Other drug delivery system formulated using microfluidic devices are emulsion [146], microgels [147], chitosan-based nanoparticles [148], polymeric microcapsules [149], and pH responsive polymer/ porous silicon composites system [150] Riahi et al [151] discussed current expert opinion in microfluidics for advanced drug delivery All in all, this effective, simple, and inexpensive fabricated microdevice is predicted to continue to flourish in biomedical research 5.2 Tissue engineering Microfabrication techniques have been used to replicate structures with well-controlled microenvironments of individuals, interactions of multiple cell clusters, and with sizes ranging from 0.1 to 10 mm Thus, microfabrication techniques are viewed as a potentially effective approach to promote highly-organized scaffolds in tissue engineering Photolithography has been used to pattern biomaterials such as proteins, cells, and extracellular matrices [152] Soft lithography implements master molds such as PDMS elastomers to product PLGA scaffolds [153e155] One study by Yang et al [156] developed a biologically benign CO2 assisted 3D scaffolds using micromolding Photolithography was first used to construct desirable patterns of SU-8100 on a substrate following by dispersion of PDMS resin The inverse PDMS mold was peeled off after h curing at 65  C In the next step, bilayer PLGA skeletons were precisely patterned by being melt at 220  C and then embossed with PDMS mold at 0.1e3 MPa as illustrated in Fig The bonded scaffolds were created by pressured saturation with CO2 at 0.69 MPa and low temperature for h Cell culture study indicated the cytocompatibility of scaffolds This work contributed a powerful, solvent-free, and low cost method to engineer well-defined Fig Cross-sectional schematic of the cantilever/polymer structure with the various dimensions Reprinted from reference [163] with the permission of AIP Publishing structure scaffolds However, possessing a common problem in tissue engineering, micro-fabricated tissue scaffolds have a limited control and ability to create effective microvascular systems within the scaffold structure [157] The merger of microfabrication and hydrogels have indeed proposed great feasibility to overcome current limitations and open new functional applications in tissue engineering [55] A review by Khademhosseinia and Langer [158] has broadly discussed perspectives of various hydrogels synthetic approaches especially microfabrication as well as its applications in tissue engineering For instance, shape-controlled cell-laden microgels fabricated by micromolding photocrosslinkable hydrogels are able to be seeded with diverse cell types and assembled to form 3D structures in highly-governed structures and cell interactions [159] Additionally, the microengineered hydrogels are of great benefits for their surface modifications Through covalently immobilized cell integrin ligand (ephrin-A1 and Arg-Gly-Asp-Ser), a vascular development factor, on PEG hydrogels surface using photopolymerization, the adhesion of endothelial cells is improved together with better control over angiogenic functions [160] A remarkable research of Yeh et al [161] also used a micromolding technique to entrap mammalian cells in 3D microscale photocrosslinked harvestable hydrogels of controlled size and shapes 5.3 Biosensors Photolithography has been employed to micropattern hydrogels for biological sensors due to the ability of hydrogels to capture a wide range of biological sensitive factors The 3D structures of microgels provide greater density of receptor molecules, hence improving sensing capacity when compared to 2D systems [162] For example, Bashir et al [163] patterned an environmentallyresponsive antibody-laden hydrogel onto a MEMS microcantilever (Fig 9) When absorbing targeted proteins, this sensitive system swelled and deflected the MEMS cantilever The degree of deflection was then calculated by refractive optics Investigations on pH and thermal sensitive hydrogels were carried out and resulted in similar findings [164] In another study, PEG hydrogels were developed as biotin-streptavidin biosensors by combining methods of surface graft polymerization and photolithography [165] Modifications of protein-repellent PEG hydrogels surface were made by grafting poly(acrylic acid) (PAA) as monomers and Fig 10 Micropatterning of PAA on the PEG hydrogel surface Optical image of 100 mm diameter circles of PAA on PEG hydrogel surface Reprinted from reference [165] with permission from Elsevier K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 benzophenone as surface initiator via photoinduced surface polymerization A photolithographic process transformed the graft polymerization surface into well-defined, pH-responsive PAA micropatterns deposited on PEG hydrogels (Fig 10) The PAA micropatterns further presented their potential as biosensors through successful molecular recognition and binding with biotin and streptavidin Conclusion With the emergence of lithography in biomedical research, several novel sets of techniques have been utilized to manufacture biomaterials with desired chemical, physical, and biological features Based on photolithography techniques, scientists have been able to develop more advanced fabrication methods which are more precise, suitable to different biomaterials and at large scale production These include but are not limited to soft lithography, micromolding, nano imprint lithography, and nano-molding PRINT particles The fact that micro- and nano-fabrications are applicable to manufacture a variety of biomaterials with a high throughput and low-production cost presents promising opportunity to rapidly bring biomaterials into clinical studies and applications These methods overcome some limitations of the chemically prepared formulation approaches Nevertheless, future research is expected to focus on combining the advantages of the two approaches for maximal treatment efficacy Conflict of interest The authors confirm that this article content has no conflicts of interest Acknowledgments We thank Albert Miller and Atta Henoun for proof-reading the manuscript We thank Academic Plan program at UConn for support on our work References [1] B.D Ratner, A.S Hoffman, F.J Schoen, J.E Lemons, Biomaterials Science: An Introduction to Materials in Medicine, Academic press, 2004 [2] D.F Williams, The Williams Dictionary of Biomaterials, Liverpool University Press, 1999 [3] E.J Haboush, Hip joint prosthesis, in, Google Patents, 1962 [4] R.B Davis, J Skelton, R.E Clark, W.M Swanson, Heart valve prosthesis, in, Google Patents, 1981 [5] B.D Ratner, A.S Hoffman, F.J Schoen, J.E Lemons, Biomaterials Science: A Multidisciplinary Endeavor, Biomaterials Science: an Introduction to Materials in Medicine, 2004, pp 1e9 [6] S Kalepu, M Manthina, V Padavala, Oral lipid-based drug delivery systemsean overview, Acta Pharm Sin B (2013) 361e372 [7] S Van Vlierberghe, P Dubruel, E Schacht, Biopolymer-based hydrogels as scaffolds for tissue engineering applications: a review, Biomacromolecules 12 (2011) 1387e1408 [8] L.C.S Glangchai, Nanoimprint lithography based fabrication of size and shape-specific, enzymatically-triggered nanoparticles for drug delivery applications, Micro Electro Mech Sys (2008) [9] M Caldorera-Moore, L Glangchai, L Shi, K Roy, Step and flash imprint lithography for the fabrication of shape-specific, enzymatically-triggered, drug nanocarriers, in: Nanotechnology 2008: Life Sciences, Medicine & Bio Materials e Technical Proceedings of the 2008 NSTI Nanotechnology Conference and Trade Show, 2008, pp 415e418 [10] P.B Meggs, A History of Graphic Design, Monthly Design Company, 1985 [11] M.C McAlpine, R.S Friedman, C.M Lieber, Nanoimprint lithography for hybrid plastic electronics, Nano Lett (2003) 443e445 [12] G.M Whitesides, E Ostuni, S Takayama, X Jiang, D.E Ingber, Soft lithography in biology and biochemistry, Annu Rev Biomed Eng (2001) 335e373 [13] L Rassaei, P.S Singh, S.G Lemay, Lithography-based nanoelectrochemistry, Anal Chem 83 (2011) 3974e3980 11 [14] A De Boer, P Gaillard, Drug targeting to the brain, Annu Rev Pharmacol Toxicol 47 (2007) 323e355 [15] W.M Pardridge, Biopharmaceutical drug targeting to the brain, J Drug Target 18 (2010) 157e167 [16] M Schenk, C Mueller, The mucosal immune system at the gastrointestinal barrier, Best Pract Res Clin Gastroenterol 22 (2008) 391e409 [17] G Lambert, Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects, J Anim Sci 87 (2009) E101eE108 [18] M.R Prausnitz, P.M Elias, T.J Franz, M Schmuth, J.-C Tsai, G.K Menon, W.M Holleran, K.R Feingold, Skin barrier and transdermal drug delivery, Dermatology (2012) 2065e2073 [19] H.S Choi, W Liu, P Misra, E Tanaka, J.P Zimmer, B.I Ipe, M.G Bawendi, J.V Frangioni, Renal clearance of quantum dots, Nat Biotechnol 25 (2007) 1165e1170 [20] A Albanese, P.S Tang, W.C Chan, The effect of nanoparticle size, shape, and surface chemistry on biological systems, Annu Rev Biomed Eng 14 (2012) 1e16 [21] Y Geng, P Dalhaimer, S Cai, R Tsai, M Tewari, T Minko, D.E Discher, Shape effects of filaments versus spherical particles in flow and drug delivery, Nat Nanotechnol (2007) 249e255 [22] T Cedervall, I Lynch, S Lindman, T Berggård, E Thulin, H Nilsson, K.A Dawson, S Linse, Understanding the nanoparticleeprotein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles, Proc Natl Acad Sci 104 (2007) 2050e2055 [23] E Blanco, H Shen, M Ferrari, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat Biotechnol 33 (2015) 941e951 [24] F Re, I Cambianica, C Zona, S Sesana, M Gregori, R Rigolio, B La Ferla, F Nicotra, G Forloni, A Cagnotto, Functionalization of liposomes with ApoEderived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model, Nanomed Nanotechnol Biol Med (2011) 551e559 [25] K Ulbrich, T Hekmatara, E Herbert, J Kreuter, Transferrin-and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the bloodebrain barrier (BBB), Eur J Pharm Biopharm 71 (2009) 251e256 [26] P Breedveld, J.H Beijnen, J.H Schellens, Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs, Trends Pharmacol Sci 27 (2006) 17e24 [27] K.B Ita, Chemical penetration enhancers for transdermal drug deliverysuccess and challenges, Curr Drug Del 12 (2015) 645e651 [28] A.C Williams, B.W Barry, Penetration enhancers, Adv Drug Del Rev 64 (2012) 128e137 [29] H Daraee, A Etemadi, M Kouhi, S Alimirzalu, A Akbarzadeh, Application of liposomes in medicine and drug delivery, Artif Cells Nanomed Biotechnol 44 (2016) 381e391 [30] V Torchilin, Targeted polymeric micelles for delivery of poorly soluble drugs, Cell Mol Life Sci 61 (2004) 2549e2559 [31] M Yukuyama, D Ghisleni, T Pinto, N Bou-Chacra, Nanoemulsion: process selection and application in cosmeticsea review, Int J Cosmet Sci 38 (2016) 13e24 € rmann, A Zimmer, Drug delivery and drug targeting with parenteral [32] K Ho lipid nanoemulsionsda review, J Control Release 223 (2016) 85e98 [33] A Garud, D Singh, N Garud, Solid lipid nanoparticles (SLN): method, characterization and applications, Int Curr Pharm J (2012) 384e393 [34] R.H Müller, M Radtke, S.A Wissing, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations, Adv Drug Del Rev 54 (2002) S131eS155 [35] S Weber, A Zimmer, J Pardeike, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art, Eur J Pharm Biopharm 86 (2014) 7e22 [36] P Mura, Analytical techniques for characterization of cyclodextrin complexes in the solid state: a review, J Pharm Biomed Anal 113 (2015) 226e238 [37] V Chaudhary, J Patel, Cyclodextrin inclusion complex to enhance solubility of poorly water soluble drugs: a review, IJPSR (2013) 68 [38] S Mazzaferro, K Bouchemal, G Ponchel, Oral delivery of anticancer drugs II: the prodrug strategy, Drug Discov Today 18 (2013) 93e98 [39] C Luo, J Sun, B Sun, Z He, Prodrug-based nanoparticulate drug delivery strategies for cancer therapy, Trends Pharmacol Sci 35 (2014) 556e566 [40] K Thi My Tran, T Van Vo, W Duan, P Ha-Lien Tran, T Truong-Dinh Tran, Perspectives of engineered marine derived polymers for biomedical nanoparticles, Curr Pharm Des 22 (2016) 2844e2856 [41] J.M Harris, R.B Chess, Effect of pegylation on pharmaceuticals, Nat Rev Drug Discov (2003) 214e221 [42] T Yamaoka, Y Tabata, Y Ikada, Distribution and tissue uptake of poly (ethylene glycol) with different molecular weights after intravenous administration to mice, J Pharm Sci 83 (1994) 601e606 [43] J.M Harris, N.E Martin, M Modi, Pegylation, Clin Pharmacokinet 40 (2001) 539e551 [44] A Gabizon, F Martin, Polyethylene glycol-coated (pegylated) liposomal doxorubicin, Drugs 54 (1997) 15e21 [45] T Yang, F.-D Cui, M.-K Choi, J.-W Cho, S.-J Chung, C.-K Shim, D.-D Kim, Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation, Int J Pharm 338 (2007) 317e326 12 K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 [46] H Yamaoka, H Asato, T Ogasawara, S Nishizawa, T Takahashi, T Nakatsuka, I Koshima, K Nakamura, H Kawaguchi, U.i Chung, Cartilage tissue engineering using human auricular chondrocytes embedded in different hydrogel materials, J Biomed Mater Res A 78 (2006) 1e11 [47] M.S Chapekar, Tissue engineering: challenges and opportunities, J Biomed Mater Res 53 (2000) 617e620 [48] P.A Gunatillake, R Adhikari, Biodegradable synthetic polymers for tissue engineering, Eur Cell Mater (2003) 1e16 [49] R Langer, Perspectives and challenges in tissue engineering and regenerative medicine, Adv Mater 21 (2009) 3235e3236 [50] S.J Bidarra, C.C Barrias, P.L Granja, Injectable alginate hydrogels for cell delivery in tissue engineering, Acta Biomater 10 (2014) 1646e1662 ro ^me, Chitosan-based biomaterials for tissue engineering, [51] F Croisier, C Je Eur Polym J 49 (2013) 780e792 [52] M.N Collins, C Birkinshaw, Hyaluronic acid based scaffolds for tissue engineeringda review, Carbohydr Polym 92 (2013) 1262e1279 [53] I Sandvig, K Karstensen, A.M Rokstad, F.L Aachmann, K Formo, A Sandvig, G Skjåk-Bræk, B.L Strand, RGD-peptide modified alginate by a chemoenzymatic strategy for tissue engineering applications, J Biomed Mater Res A 103 (2015) 896e906 [54] S Ganta, H Devalapally, A Shahiwala, M Amiji, A review of stimuliresponsive nanocarriers for drug and gene delivery, J Control Release 126 (2008) 187e204 [55] M Caldorera-Moore, N.A Peppas, Micro-and nanotechnologies for intelligent and responsive biomaterial-based medical systems, Adv Drug Del Rev 61 (2009) 1391e1401 [56] P Gupta, K Vermani, S Garg, Hydrogels: from controlled release to pHresponsive drug delivery, Drug Discov Today (2002) 569e579 [57] B Lele, A Hoffman, Mucoadhesive drug carriers based on complexes of poly (acrylic acid) and PEGylated drugs having hydrolysable PEGeanhydrideedrug linkages, J Control Release 69 (2000) 237e248 [58] S Dwivedi, Hydrogel-A conceptual overview, Int J Pharm Biol Arch (2011) [59] V Kozlovskaya, E Kharlampieva, M.L Mansfield, S.A Sukhishvili, Poly (methacrylic acid) hydrogel films and capsules: response to pH and ionic strength, and encapsulation of macromolecules, Chem Mater 18 (2006) 328e336 [60] A.S Hoffman, Hydrogels for biomedical applications, Adv Drug Del Rev 64 (2012) 18e23 [61] B Demirdirek, K.E Uhrich, Salicylic acid-based pH-sensitive hydrogels as potential oral insulin delivery systems, J Drug Target 23 (2015) 716e724 [62] C Gao, J Ren, C Zhao, W Kong, Q Dai, Q Chen, C Liu, R Sun, Xylan-based temperature/pH sensitive hydrogels for drug controlled release, Carbohydr Polym 151 (2016) 189e197 [63] M.C Koetting, J.F Guido, M Gupta, A Zhang, N.A Peppas, pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: effects of protein size, crosslinking density, and hydrogel degradation on protein delivery, J Control Release 221 (2016) 18e25  , V.V Khutoryanskiy, Biomedical applications of hydrogels: a review of [64] E Calo patents and commercial products, Eur Polym J 65 (2015) 252e267 [65] S Mavuso, T Marimuthu, Y.E Choonara, P Kumar, L.C du Toit, V Pillay, A review of polymeric colloidal nanogels in transdermal drug delivery, Curr Pharm Des 21 (2015) 2801e2813 [66] X.Y Bai, Y Yan, L Wang, L.G Zhao, K Wang, Novel pH-sensitive hydrogels for 5-aminosalicylic acid colon targeting delivery: in vivo study with ulcerative colitis targeting therapy in mice, Drug Deliv (2015) 1e7 [67] M Karimi, M Eslami, P Sahandi-Zangabad, F Mirab, N Farajisafiloo, Z Shafaei, D Ghosh, M Bozorgomid, F Dashkhaneh, M.R Hamblin, pHsensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents, Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) [68] F.D Jochum, P Theato, Temperature-and light-responsive smart polymer materials, Chem Soc Rev 42 (2013) 7468e7483 [69] Y Qiu, K Park, Environment-sensitive hydrogels for drug delivery, Adv Drug Del Rev 53 (2001) 321e339 szlo , B Iv [70] G Kali, S Vavra, K La an, Thermally responsive amphiphilic conetworks and gels based on poly (N-isopropylacrylamide) and polyisobutylene, Macromolecules 46 (2013) 5337e5344 [71] N.A Cortez-Lemus, A Licea-Claverie, Poly (N-vinylcaprolactam), a comprehensive review on a thermoresponsive polymer becoming popular, Prog Polym Sci 53 (2016) 1e51 [72] H.-F Liang, M.-H Hong, R.-M Ho, C.-K Chung, Y.-H Lin, C.-H Chen, H.W Sung, Novel method using a temperature-sensitive polymer (methylcellulose) to thermally gel aqueous alginate as a pH-sensitive hydrogel, Biomacromolecules (2004) 1917e1925 [73] J Zhang, N.A Peppas, Synthesis and characterization of pH-and temperaturesensitive poly (methacrylic acid)/poly (N-isopropylacrylamide) interpenetrating polymeric networks, Macromolecules 33 (2000) 102e107 [74] Y Zhan, M Gonỗalves, P Yi, D Capelo, Y Zhang, J Rodrigues, C Liu, H Tom as, Y Li, P He, Thermo/redox/pH-triple sensitive poly (N-isopropylacrylamideco-acrylic acid) nanogels for anticancer drug delivery, J Mater Chem B (2015) 4221e4230 [75] K Rezwan, Q Chen, J Blaker, A.R Boccaccini, Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering, Biomaterials 27 (2006) 3413e3431 [76] K.Y Lee, D.J Mooney, Hydrogels for tissue engineering, Chem Rev 101 (2001) 1869e1880 [77] A Kogan, N Garti, Microemulsions as transdermal drug delivery vehicles, Adv Colloid Interface Sci 123 (2006) 369e385 [78] W.L Chiou, S Riegelman, Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin, J Pharm Sci 58 (1969) 1505e1510 [79] L.A Nikghalb, G Singh, G Singh, K.F Kahkeshan, Solid Dispersion: methods and polymers to increase the solubility of poorly soluble drugs, J Appl Pharm Sci (2012) 170e175 [80] R Langer, Drug deliveryand targeting, Nature 392 (1998) 5e10 [81] L.E Euliss, J.A DuPont, S Gratton, J DeSimone, Imparting size, shape, and composition control of materials for nanomedicine, Chem Soc Rev 35 (2006) 1095e1104 [82] G Domokos, B Jopski, K.H Schmidt, Preparation, properties and biological function of liposome encapsulated hemoglobin, Biomater Artif Cells Immobil Biotechnol 20 (1992) 345e354 [83] S Li, B Byrne, J Welsh, A.F Palmer, Self-assembled poly (butadiene)-b-poly (ethylene oxide) polymersomes as paclitaxel carriers, Biotechnol Prog 23 (2007) 278e285 [84] E.J Curry, A.D Henoun, A.N Miller III, T.D Nguyen, 3D nano- and micropatterning of biomaterials for controlled drug delivery, Ther Deliv (1) (2016) 15e28 [85] A.J Dallas, K.M Graham, M Clarysse, V Fonderle, Characterization and control of organic airborne contamination in lithographic processing, in: SPIE's 27th Annual International Symposium on Microlithography, International Society for Optics and Photonics, 2002, pp 1085e1109 [86] W Den, H Bai, Y Kang, Organic airborne molecular contamination in semiconductor fabrication clean rooms a review, J Electrochem Soc 153 (2006) G149eG159 [87] M.J Madou, Fundamentals of Microfabrication: The Science of Miniaturization, CRC press, 2002 [88] T.T Lee, J.R García, J.I Paez, A Singh, E.A Phelps, S Weis, Z Shafiq, A Shekaran, A Del Campo, A.J García, Light-triggered in vivo activation of adhesive peptides regulates cell adhesion, inflammation and vascularization of biomaterials, Nat Mater 14 (2015) 352e360 [89] A del Campo, E Arzt, Fabrication approaches for generating complex microand nanopatterns on polymeric surfaces, Chem Rev 108 (2008) 911e945 [90] H Levinson, Principles of Lithography, SPIE, Washington, DC, 2001 [91] D Qin, Y Xia, G.M Whitesides, Soft lithography for micro-and nanoscale patterning, Nat Protoc (2010) 491e502 [92] P.-G de Gennes, Introductory lecture Mechanics of soft interfaces, Farad Discuss 104 (1996) 1e8 [93] C James, R Davis, L Kam, H Craighead, M Isaacson, J Turner, W Shain, Patterned protein layers on solid substrates by thin stamp microcontact printing, Langmuir 14 (1998) 741e744 [94] Y Xia, G.M Whitesides, Soft lithography, Annu Rev Mater Sci 28 (1998) 153e184 [95] R.S Kane, S Takayama, E Ostuni, D.E Ingber, G.M Whitesides, Patterning proteins and cells using soft lithography, Biomaterials 20 (1999) 2363e2376 [96] Y Xia, J.J McClelland, R Gupta, D Qin, X.M Zhao, L.L Sohn, R.J Celotta, G.M Whitesides, Replica molding using polymeric materials: a practical step toward nanomanufacturing, Adv Mater (1997) 147e149 [97] X.M Zhao, Y Xia, G.M Whitesides, Fabrication of three-dimensional microstructures: microtransfer molding, Adv Mater (1996) 837e840 [98] S Jeon, E Menard, J.U Park, J Maria, M Meitl, J Zaumseil, J.A Rogers, Threedimensional nanofabrication with rubber stamps and conformable photomasks, Adv Mater 16 (2004) 1369e1373 [99] E King, Y Xia, X.M Zhao, G.M Whitesides, Solvent-assisted microcontact molding: a convenient method for fabricating three-dimensional structures on surfaces of polymers, Adv Mater (1997) 651e654 [100] T.W Odom, J.C Love, D.B Wolfe, K.E Paul, G.M Whitesides, Improved pattern transfer in soft lithography using composite stamps, Langmuir 18 (2002) 5314e5320 [101] W.R Childs, R.G Nuzzo, Decal transfer microlithography: a new softlithographic patterning method, J Am Chem Soc 124 (2002) 13583e13596 [102] Q Xu, R.M Rioux, M.D Dickey, G.M Whitesides, Nanoskiving: a new method to produce arrays of nanostructures, Acc Chem Res 41 (2008) 1566e1577 [103] M.C Traub, W Longsine, V.N Truskett, Advances in nanoimprint lithography, Annu Rev Chem Biomol Eng (2016) 583e604 [104] S.Y Chou, P.R Krauss, P.J Renstrom, Nanoimprint lithography, J Vac Sci Technol B 14 (1996) 4129e4133 [105] M Bender, M Otto, B Hadam, B Vratzov, B Spangenberg, H Kurz, Fabrication of nanostructures using a UV-based imprint technique, Microelectron Eng 53 (2000) 233e236 [106] S.Y Chou, Nanoimprint lithography and lithographically induced self-assembly, Mrs Bull 26 (2001) 512e517 [107] N Koo, M Bender, U Plachetka, A Fuchs, T Wahlbrink, J Bolten, H Kurz, Improved mold fabrication for the definition of high quality nanopatterns by Soft UV-Nanoimprint lithography using diluted PDMS material, Microelectron Eng 84 (2007) 904e908 [108] L.J Guo, Recent progress in nanoimprint technology and its applications, J Phys D Appl Phys 37 (2004) R123 K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 [109] S.H Ahn, L.J Guo, Large-area roll-to-roll and roll-to-plate nanoimprint lithography: a step toward high-throughput application of continuous nanoimprinting, ACS Nano (2009) 2304e2310 [110] J Xu, D.H Wong, J.D Byrne, K Chen, C Bowerman, J.M DeSimone, Future of the particle replication in nonwetting templates (PRINT) technology, Angew Chem 52 (2013) 6580e6589 [111] J.P Rolland, B.W Maynor, L.E Euliss, A.E Exner, G.M Denison, J.M DeSimone, Direct fabrication and harvesting of monodisperse, shapespecific nanobiomaterials, J Am Chem Soc 127 (2005) 10096e10100 [112] J.Y Kelly, J.M DeSimone, Shape-specific, monodisperse nano-molding of protein particles, J Am Chem Soc 130 (2008) 5438e5439 [113] S.E Gratton, M.E Napier, P.A Ropp, S Tian, J.M DeSimone, Microfabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of PRINT particles, Pharm Res 25 (2008) 2845e2852 [114] J.P Rolland, R.M Van Dam, D.A Schorzman, S.R Quake, J.M DeSimone, Solvent-resistant photocurable “liquid teflon” for microfluidic device fabrication, J Am Chem Soc 126 (2004) 2322e2323 [115] T.J Merkel, K.P Herlihy, J Nunes, R.M Orgel, J.P Rolland, J.M DeSimone, Scalable, shape-specific, top-down fabrication methods for the synthesis of engineered colloidal particles, Langmuir 26 (2009) 13086e13096 [116] J.A Champion, Y.K Katare, S Mitragotri, Making polymeric micro-and nanoparticles of complex shapes, Proc Natl Acad Sci 104 (2007) 11901e11904 [117] R.A Petros, P.A Ropp, J.M DeSimone, Reductively labile PRINT particles for the delivery of doxorubicin to HeLa cells, J Am Chem Soc 130 (2008) 5008e5009 [118] J.L Perry, K.P Herlihy, M.E Napier, J.M DeSimone, PRINT: a novel platform toward shape and size specific nanoparticle theranostics, Acc Chem Res 44 (2011) 990e998 [119] G Bachand, R Soong, H Neves, A Olkhovets, H Craighead, C Montemagno, Precision attachment of individual F1-ATPase biomolecular motors on nanofabricated substrates, Nano Lett (2001) 42e44 [120] Y Cho, J Park, H Park, X Cheng, B Kim, A Han, Fabrication of high-aspectratio polymer nanochannels using a novel Si nanoimprint mold and solventassisted sealing, Microfluid Nanofluid (2010) 163e170 [121] R.A Segalman, H Yokoyama, E.J Kramer, Graphoepitaxy of spherical domain block copolymer films, Adv Mater 13 (2001) 1152e1155 [122] V.S Voet, T.E Pick, S.-M Park, M Moritz, A.T Hammack, J.J Urban, D.F Ogletree, D.L Olynick, B.A Helms, Interface segregating fluoralkylmodified polymers for high-fidelity block copolymer nanoimprint lithography, J Am Chem Soc 133 (2011) 2812e2815 [123] G Mapili, Y Lu, S Chen, K Roy, Laser-layered microfabrication of spatially patterned functionalized tissue-engineering scaffolds, J Biomed Mater Res Part B Appl Biomater 75 (2005) 414e424 [124] T.K Ghosh, W.R Pfister, S.I Yum, Transdermal and topical drug delivery systems, Inf Health Care (1997) [125] V Kusum Devi, S Saisivam, G Maria, P Deepti, Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride, Drug Dev Ind Pharm 29 (2003) 495e503 [126] S.T Blackman, I Ralske, Gel bases for pharmaceutical compositions, in, Google Patents, 1989 [127] K Frederiksen, R.H Guy, K Petersson, The potential of polymeric filmforming systems as sustained delivery platforms for topical drugs, Expert Opin Drug Deliv 13 (2016) 349e360 [128] R.K Sivamani, D Liepmann, H.I Maibach, Microneedles and transdermal applications, Expert Opin Drug Deliv (2007) 19e25 [129] S Henry, D.V McAllister, M.G Allen, M.R Prausnitz, Microfabricated microneedles: a novel approach to transdermal drug delivery, J Pharm Sci 87 (1998) 922e925 [130] H Jansen, M de Boer, B Otter, M Elwenspoek, The black silicon method IV The fabrication of three-dimensional structures in silicon with high apect ratios for scanning probe microscopy and other applications, in: Micro Electro Mechanical Systems, 1995, MEMS'95, Proceedings IEEE, IEEE, 1995, p 88 [131] J.-H Park, M.G Allen, M.R Prausnitz, Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery, J Control Release 104 (2005) 51e66 [132] S.P Davis, W Martanto, M.G Allen, M.R Prausnitz, Hollow metal microneedles for insulin delivery to diabetic rats, IEEE Trans Biomed Eng 52 (2005) 909e915 [133] P.M Wang, M Cornwell, J Hill, M.R Prausnitz, Precise microinjection into skin using hollow microneedles, J Invest Dermatol 126 (2006) 1080e1087 [134] S Bystrova, R Luttge, Micromolding for ceramic microneedle arrays, Microelectron Eng 88 (2011) 1681e1684 [135] R.F Donnelly, R Majithiya, T.R.R Singh, D.I Morrow, M.J Garland, Y.K Demir, K Migalska, E Ryan, D Gillen, C.J Scott, Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laserbased micromoulding technique, Pharm Res 28 (2011) 41e57 [136] T Omatsu, K Chujo, K Miyamoto, M Okida, K Nakamura, N Aoki, R Morita, Metal microneedle fabrication using twisted light with spin, Opt Express 18 (2010) 17967e17973 [137] M.C Gower, Industrial applications of laser micromachining, Opt Express (2000) 56e67 [138] A.A Fomani, R.R Mansour, Fabrication and characterization of the flexible neural microprobes with improved structural design, Sens Actuators A Phys 168 (2011) 233e241 13 [139] S.-O Choi, Y.C Kim, J.-H Park, J Hutcheson, H.S Gill, Y.-K Yoon, M.R Prausnitz, M.G Allen, An electrically active microneedle array for electroporation, Biomed Microdevices 12 (2010) 263e273 [140] D.V McAllister, P.M Wang, S.P Davis, J.-H Park, P.J Canatella, M.G Allen, M.R Prausnitz, Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies, Proc Natl Acad Sci 100 (2003) 13755e13760 [141] M Shearn, X Sun, M.D Henry, A Yariv, A Scherer, Advanced plasma processing: etching, deposition, and wafer bonding techniques for semiconductor applications, Intech (2010) [142] M Kim, B Jung, J.-H Park, Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin, Biomaterials 33 (2012) 668e678 [143] G.M Whitesides, The origins and the future of microfluidics, Nature 442 (2006) 368e373 [144] J.C McDonald, G.M Whitesides, Poly (dimethylsiloxane) as a material for fabricating microfluidic devices, Acc Chem Res 35 (2002) 491e499 [145] Q Xu, M Hashimoto, T.T Dang, T Hoare, D.S Kohane, G.M Whitesides, R Langer, D.G Anderson, Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery, Small (2009) 1575e1581 [146] C.-X Zhao, Multiphase flow microfluidics for the production of single or multiple emulsions for drug delivery, Adv Drug Del Rev 65 (2013) 1420e1446 [147] M.N Hsu, R Luo, K.Z Kwek, Y.C Por, Y Zhang, C.-H Chen, Sustained release of hydrophobic drugs by the microfluidic assembly of multistage microgel/ poly (lactic-co-glycolic acid) nanoparticle composites, Biomicrofluidics (2015) 052601 [148] F.S Majedi, M.M Hasani-Sadrabadi, S.H Emami, M.A Shokrgozar, J.J VanDersarl, E Dashtimoghadam, A Bertsch, P Renaud, Microfluidic assisted self-assembly of chitosan based nanoparticles as drug delivery agents, Lab Chip 13 (2013) 204e207 [149] J Pessi, H.A Santos, I Miroshnyk, D.A Weitz, S Mirza, Microfluidics-assisted engineering of polymeric microcapsules with high encapsulation efficiency for protein drug delivery, Int J Pharm 472 (2014) 82e87 €, V.P Lehto, J Salonen, [150] D Liu, H Zhang, B Herranz-Blanco, E M€ akila J Hirvonen, H.A Santos, Microfluidic assembly of monodisperse multistage pH-responsive polymer/porous silicon composites for precisely controlled multi-drug delivery, Small 10 (2014) 2029e2038 [151] R Riahi, A Tamayol, S.A.M Shaegh, A.M Ghaemmaghami, M.R Dokmeci, A Khademhosseini, Microfluidics for advanced drug delivery systems, Curr Opin Chem Eng (2015) 101e112 [152] Z Chen, S He, H.J Butt, S Wu, Photon upconversion lithography: patterning of biomaterials using near-infrared light, Adv Mater 27 (2015) 2203e2206 [153] G Vozzi, C.J Flaim, F Bianchi, A Ahluwalia, S Bhatia, Microfabricated PLGA scaffolds: a comparative study for application to tissue engineering, Mater Sci Eng C 20 (2002) 43e47 [154] J.T Borenstein, E.J Weinberg, B.K Orrick, C Sundback, M.R KaazempurMofrad, J.P Vacanti, Microfabrication of three-dimensional engineered scaffolds, Tissue Eng 13 (2007) 1837e1844 [155] C.J Bettinger, J.T Borenstein, R Langer, Microfabrication techniques in scaffold development, Nanotechnology and Regenerative Engineering: The Scaffold, 2014, p 103 [156] Y Yang, S Basu, D.L Tomasko, L.J Lee, S.-T Yang, Fabrication of well-defined PLGA scaffolds using novel microembossing and carbon dioxide bonding, Biomaterials 26 (2005) 2585e2594 [157] J.T Borenstein, H Terai, K.R King, E Weinberg, M Kaazempur-Mofrad, J Vacanti, Microfabrication technology for vascularized tissue engineering, Biomed Microdevices (2002) 167e175 [158] A Khademhosseini, R Langer, Microengineered hydrogels for tissue engineering, Biomaterials 28 (2007) 5087e5092 [159] B.G Chung, K.-H Lee, A Khademhosseini, S.-H Lee, Microfluidic fabrication of microengineered hydrogels and their application in tissue engineering, Lab Chip 12 (2012) 45e59 [160] J.J Moon, S.-H Lee, J.L West, Synthetic biomimetic hydrogels incorporated with ephrin-A1 for therapeutic angiogenesis, Biomacromolecules (2007) 42e49 [161] J Yeh, Y Ling, J.M Karp, J Gantz, A Chandawarkar, G Eng, J Blumling Iii, R Langer, A Khademhosseini, Micromolding of shape-controlled, harvestable cell-laden hydrogels, Biomaterials 27 (2006) 5391e5398 [162] W Zhan, G.H Seong, R.M Crooks, Hydrogel-based microreactors as a functional component of microfluidic systems, Anal Chem 74 (2002) 4647e4652 [163] R Bashir, J Hilt, O Elibol, A Gupta, N Peppas, Micromechanical cantilever as an ultrasensitive pH microsensor, Appl Phys Lett 81 (2002) 3091e3093 [164] J.Z Hilt, A.K Gupta, R Bashir, N.A Peppas, Ultrasensitive biomems sensors based on microcantilevers patterned with environmentally responsive hydrogels, Biomed Microdevices (2003) 177e184 [165] W Lee, D Choi, Y Lee, D.-N Kim, J Park, W.-G Koh, Preparation of micropatterned hydrogel substrate via surface graft polymerization combined with photolithography for biosensor application, Sens Actuators B Chem 129 (2008) 841e849 [166] T.R Hoare, D.S Kohane, Hydrogels in drug delivery: progress and challenges, Polymer 49 (2008) 1993e2007 [167] Y Ma, J Thiele, L Abdelmohsen, J Xu, W.T Huck, Biocompatible macroinitiators controlling radical retention in microfluidic on-chip photopolymerization of water-in-oil emulsions, Chem Commun 50 (2014) 112e114 14 K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 € mpers, A van der Hart, C Kügeler, A Offenh€ [168] S Gilles, M Meier, M Pro ausser, D Mayer, UV nanoimprint lithography with rigid polymer molds, Microelectron Eng 86 (2009) 661e664 [169] S.E Gratton, P.D Pohlhaus, J Lee, J Guo, M.J Cho, J.M DeSimone, Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT™ nanoparticles, J Control Release 121 (2007) 10e18 [170] Y.-C Kim, J.-H Park, M.R Prausnitz, Microneedles for drug and vaccine delivery, Adv Drug Del Rev 64 (2012) 1547e1568 [171] P Marizza, S.S Keller, A Müllertz, A Boisen, Polymer-filled microcontainers for oral delivery loaded using supercritical impregnation, J Control Release 173 (2014) 1e9 [172] H.S Gill, M.R Prausnitz, Coated microneedles for transdermal delivery, J Control Release 117 (2007) 227e237 [173] K van der Maaden, R Luttge, P.J Vos, J Bouwstra, G Kersten, I Ploemen, Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays, Drug Deliv Transl Res (2015) 397e406 [174] W Martanto, S.P Davis, N.R Holiday, J Wang, H.S Gill, M.R Prausnitz, Transdermal delivery of insulin using microneedles in vivo, Pharm Res 21 (2004) 947e952 [175] M Kaur, K.B Ita, I.E Popova, S.J Parikh, D.A Bair, Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate, Eur J Pharm Biopharm 86 (2014) 284e291 [176] A Puri, H.X Nguyen, A.K Banga, Microneedle-mediated intradermal delivery of epigallocatechin-3-gallate, Int J Cosmet Sci (2016) [177] P.E Daddona, J.A Matriano, J Mandema, Y.-F Maa, Parathyroid hormone (134)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis, Pharm Res 28 (2011) 159e165 [178] A Marin, A.K Andrianov, CarboxymethylcelluloseeChitosan-coated microneedles with modulated hydration properties, J Appl Polym Sci 121 (2011) 395e401 [179] M Cormier, B Johnson, M Ameri, K Nyam, L Libiran, D.D Zhang, P Daddona, Transdermal delivery of desmopressin using a coated microneedle array patch system, J Control Release 97 (2004) 503e511 [180] N.R Hegde, S.V Kaveri, J Bayry, Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination, Drug Discov Today 16 (2011) 1061e1068 [181] A.K Andrianov, D.P DeCollibus, H.A Gillis, H.K Henry, A Marin, M.R Prausnitz, L.A Babiuk, H Townsend, G Mutwiri, Poly [di (carboxylatophenoxy) phosphazene] is a potent adjuvant for intradermal immunization, Proc Natl Acad Sci 106 (2009) 18936e18941 [182] Y.-C Kim, F.-S Quan, R.W Compans, S.-M Kang, M.R Prausnitz, Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity, J Control Release 142 (2010) 187e195 [183] R.C Kines, V Zarnitsyn, T.R Johnson, Y.-Y.S Pang, K.S Corbett, J.D Nicewonger, A Gangopadhyay, M Chen, J Liu, M.R Prausnitz, Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles, PloS One 10 (2015) e0120797 [184] C Edens, M.L Collins, J Ayers, P.A Rota, M.R Prausnitz, Measles vaccination using a microneedle patch, Vaccine 31 (2013) 3403e3409 [185] T.W Prow, X Chen, N.A Prow, G.J Fernando, C.S Tan, A.P Raphael, D Chang, M.P Ruutu, D.W Jenkins, A Pyke, Nanopatch-targeted skin vaccination [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] against West Nile virus and chikungunya virus in mice, Small (2010) 1776e1784 €derholm, M.R Prausnitz, M Sa €llberg, Cutaneous vaccination H.S Gill, J So using microneedles coated with hepatitis C DNA vaccine, Gene Ther 17 (2010) 811e814 X Chen, A.S Kask, M.L Crichton, C McNeilly, S Yukiko, L Dong, J.O Marshak, C Jarrahian, G.J Fernando, D Chen, Improved DNA vaccination by skintargeted delivery using dry-coated densely-packed microprojection arrays, J Control Release 148 (2010) 327e333 M Kim, H Yang, H Kim, H Jung, Novel cosmetic patches for wrinkle improvement: retinyl retinoate-and ascorbic acid-loaded dissolving microneedles, Int J Cosmet Sci 36 (2014) 207e212 M.-H Ling, M.-C Chen, Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats, Acta Biomater (2013) 8952e8961 Y Ito, J.-I Yoshimitsu, K Shiroyama, N Sugioka, K Takada, Self-dissolving microneedles for the percutaneous absorption of EPO in mice, J Drug Target 14 (2006) 255e261 J.W Lee, S.O Choi, E.I Felner, M.R Prausnitz, Dissolving microneedle patch for transdermal delivery of human growth hormone, Small (2011) 531e539 Y Qiu, L Guo, S Zhang, B Xu, Y Gao, Y Hu, J Hou, B Bai, H Shen, P Mao, DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN, Drug Deliv (2015) U.O H€ afeli, A Mokhtari, D Liepmann, B Stoeber, In vivo evaluation of a microneedle-based miniature syringe for intradermal drug delivery, Biomed Microdevices 11 (2009) 943e950 F Amirouche, Y Zhou, T Johnson, Current micropump technologies and their biomedical applications, Microsys Technol 15 (2009) 647e666 W Martanto, J.S Moore, O Kashlan, R Kamath, P.M Wang, J.M O'Neal, M.R Prausnitz, Microinfusion using hollow microneedles, Pharm Res 23 (2006) 104e113 C.J Rini, E McVey, D Sutter, S Keith, H.-J Kurth, L Nosek, C Kapitza, K Rebrin, L Hirsch, R.J Pettis, Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear, Drug Deliv Transl Res (2015) 332e345 I Mansoor, J Lai, S Ranamukhaarachchi, V Schmitt, D Lambert, J Dutz, U.O H€ afeli, B Stoeber, A microneedle-based method for the characterization of diffusion in skin tissue using doxorubicin as a model drug, Biomed Microdevices 17 (2015) 1e10 H Jun, M.-R Han, N.-G Kang, J.-H Park, J.H Park, Use of hollow microneedles for targeted delivery of phenylephrine to treat fecal incontinence, J Control Release 207 (2015) 1e6 S Marshall, L.J Sahm, A.C Moore, The success of microneedle-mediated vaccine delivery into skin, Hum Vaccin Immunother (2016), 00e00 P Schipper, K van der Maaden, S Romeijn, C Oomens, G Kersten, W Jiskoot, J Bouwstra, Repeated fractional intradermal dosing of an inactivated polio vaccine by a single hollow microneedle leads to superior immune responses, J Control Release (2016)  ... regulator for entry into the body SC prevents entrance of therapeutic agents except for that of lipophilic and low K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) ... little toxicity and is able to be further eliminated K.T.M Tran, T.D Nguyen / Journal of Science: Advanced Materials and Devices (2017) 1e14 in urine or feces [42,43] Pegylated liposomes that form... Science: Advanced Materials and Devices (2017) 1e14 Fig Schematic of photolithography [167] (a) The wafer is cleaned to remove any unwanted contaminants (b) The photoresist is spin coated onto